Loading...
A conserved dendritic-cell regulatory program limits antitumour immunity
Checkpoint blockade therapies have improved cancer treatment, but such immunotherapy regimens fail in a large subset of patients. Conventional type 1 dendritic cells (DC1s) control the response to checkpoint blockade in preclinical models and are associated with better overall survival in patients w...
Na minha lista:
| Udgivet i: | Nature |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7787191/ https://ncbi.nlm.nih.gov/pubmed/32269339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41586-020-2134-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|